Leaderboard Ad

The Ethics of Surgical Innovation

“As surgeons, we are interested in providing the best patient care in a competitive environment that is constantly changing. We often are confronted with new technologies, and it can be difficult for surgeons to assess whether these new technologies are truly safe and efficacious.”

Ronald B. Kuppersmith, MD, MBA

Ronald B. Kuppersmith, MD, MBA

Dr. Kuppersmith will deliver this year’s John Conley, MD Lecture on Medical Ethics. During his presentation, “The Ethics of Surgical Innovation,” Dr. Kuppersmith will highlight the importance of the otolaryngologist’s role in ensuring that basic ethical principles are met when introducing new technology into a clinical setting. He will describe the innovation cycle, the definition of innovation in surgery, and its impact on different stakeholders. Finally, he will cover the potential problems that may arise during the innovation process, the potential conflicts of interest, and solutions that recognize common interests that benefit patients and facilitate innovation in otolaryngology.

“It is important for surgeons to understand where these innovations come from and how they are regulated,” he said. “This will help them make smart choices about when it is appropriate to adopt new techniques. Physicians have a critical role in the innovation process, both with respect to accountability and protecting patients’ interests.”

John Conley, MD Lecture on Medical Ethics

Today, 10:00 – 11:00 am

GWCC, Building B, Ballrooms 2-3

Dr. Kuppersmith is in private practice in Bryan-College Station and Huntsville, TX, and holds an academic appointment as Professor of Surgery at the Texas A&M Health Science Center College of Medicine. He is a Past President of the AAO-HNS and the Texas Association of Otolaryngology-Head and Neck Surgery. He currently serves on the Board of Directors of the American Board of Otolaryngology and as Deputy Editor of ENT Today.

Dr. Kuppersmith has always been interested in innovation in healthcare. He designed surgical instrumentation that is used worldwide for robot-assisted thyroid surgery and has served as a principal investigator on studies to help medical device companies obtain FDA clearance for new technologies. He frequently advises medical device companies, technology companies, and investors on clinical, market, business development, and strategic issues.

Dr. Kuppersmith attended the University of Michigan in Ann Arbor, MI, for his undergraduate degree and medical school. He completed his residency in otolaryngology-head and neck surgery at Baylor College of Medicine in Houston, TX, and obtained an MBA from University of Washington in Seattle, WA.